Clinical trial

Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study

NCT07739511

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-07-29

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2026-07-29Date precision: day

Registry last updated2026-08-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HER2 + Breast Cancerunresolved

Interventions

Paclitaxel oral solution plus Trastuzumab and PertuzumabCOMBINATION_PRODUCT

Sponsors & collaborators

Liu Shulead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07739511 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.